↑ トップへ ← 戻る

 Drug(薬物リスト) ALL | DrugBank 

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

81 / 12,172 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名(臨床試験情報から抽出)   DrugBank   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   Acetaminophen   Acetaminophen   D00217   2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   11件:
13,
34,
35,
46,
49,
51,
70,
86,
231,
256,
271 
 2   Acetaminophen/paracetamol   Acetaminophen   D00217   2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   1件:
35 
 3   Acetate   Acetate   -   -   -   40件:
1,
2,
6,
10,
13,
35,
40,
46,
49,
51,
60,
64,
70,
71,
73,
75,
76,
78,
81,
83,
85,
86,
88,
90,
96,
97,
113,
145,
156,
162,
171,
206,
222,
224,
225,
235,
265,
288,
298,
299 
 4   Antihistamine (cetirizine or equivalent)   Cetirizine   D00664, D07662   1件: HRH1   2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   1件:
35 
 5   Argx-113   -   -   -   -   3件:
11,
35,
63 
 6   Azathioprine   Azathioprine   D00238, D03033   -   -   18件:
11,
13,
19,
35,
42,
43,
44,
45,
46,
49,
65,
66,
85,
94,
95,
96,
97,
162 
 7   Carboxymethylcellulose   Carboxymethylcellulose   D07622   -   -   2件:
35,
162 
 8   Cellcept 500 mg comprimidos recubiertos   -   -   -   -   1件:
35 
 9   Cellcept®   -   -   -   -   1件:
35 
 10   Cellcept® in autoimmune bullous dermatoses   -   -   -   -   2件:
35,
162 
 11   Cellcept®500 mg comprimidos   -   -   -   -   1件:
35 
 12   Cellulose   Microcrystalline cellulose   D00093   -   -   2件:
35,
162 
 13   Cetirizine   Cetirizine   D00664, D07662   1件: HRH1   2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   2件:
13,
35 
 14   Cohort 1: 1.0 x 10^8 polytregs   -   -   -   -   1件:
35 
 15   Cohort 2: 2.5x10^8 polytregs   -   -   -   -   1件:
35 
 16   Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine   Azathioprine, Dexamethasone, Rituximab   D00238, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D02994, D03033   2件: MS4A1, NR3C1   2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction   1件:
35 
 17   Cortancyl   Prednisone acetate, cortancyl   D00068, D02798, D04855, D06542, D08416   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   3件:
35,
41,
162 
 18   Cortancyl 20 mg   Prednisone acetate, cortancyl   D00068, D02798, D04855, D06542, D08416   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   2件:
35,
162 
 19   Cotton   Cotton   -   -   -   2件:
35,
162 
 20   Cyclophosphamide   Cyclophosphamide   D00287, D07760   -   -   43件:
13,
14,
16,
19,
20,
26,
28,
35,
36,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
52,
56,
60,
61,
62,
65,
66,
84,
85,
93,
96,
162,
164,
172,
222,
224,
265,
274,
283,
284,
285,
288,
326,
331 
 21   Dapsone   Dapsone   D00592   -   -   4件:
35,
42,
60,
84 
 22   Dermoval   -   -   -   -   2件:
35,
162 
 23   Dexamethasone   Dexamethasone   D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   20件:
13,
16,
28,
35,
46,
53,
63,
65,
70,
74,
75,
81,
83,
84,
90,
96,
97,
222,
296,
299 
 24   Dexamethasone (50mg 1dd6, 3 consecutive days/month)   Dexamethasone   D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
35 
 25   Efgartigimod   -   -   -   -   1件:
35 
 26   Enbrel (etanercept)   Water, Etanercept   D00001, D00742   2件: LTA, TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   3件:
35,
46,
271 
 27   Etanercept   Etanercept   D00742   2件: LTA, TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   14件:
15,
35,
38,
39,
46,
50,
53,
56,
60,
85,
228,
271,
285,
298 
 28   Filgrastim   Filgrastim   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   25件:
2,
6,
13,
25,
26,
28,
34,
35,
40,
41,
42,
45,
46,
49,
51,
60,
62,
65,
96,
113,
164,
283,
284,
285,
331 
 29   General corticotherapy   -   -   -   -   1件:
35 
 30   Glycine   Glycine   D00011   -   -   4件:
35,
86,
226,
299 
 31   Gsk1841157   -   -   -   -   3件:
13,
35,
46 
 32   Hematopoietic stem cell transplantation   -   -   -   -   12件:
11,
13,
14,
19,
20,
35,
46,
49,
51,
96,
234,
285 
 33   Human interleukin-2   Human interleukin-2   -   -   -   1件:
35 
 34   Ianalumab   -   -   -   -   3件:
35,
49,
53 
 35   Imatinib   Imatinib   D01441, D08066   3件: ABL1, KIT, PDGFRA   3件: Chronic myeloid leukemia, MAPK signaling pathway, Pathways in cancer   11件:
13,
28,
34,
35,
46,
51,
85,
86,
87,
89,
162 
 36   Infliximab   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   22件:
35,
37,
38,
39,
40,
41,
43,
45,
46,
49,
50,
56,
65,
84,
95,
96,
97,
98,
162,
164,
269,
271 
 37   Interleukin-2   Human interleukin-2   -   -   -   6件:
2,
35,
49,
55,
65,
97 
 38   Intratect   -   -   -   -   3件:
13,
35,
65 
 39   Intratect 5%   -   -   -   -   1件:
35 
 40   Intravenous immunoglobulin   Immune Globulin Human   -   -   -   16件:
2,
11,
14,
17,
18,
35,
38,
39,
49,
51,
63,
65,
85,
164,
296,
309 
 41   Kc706   KC706   -   -   -   2件:
35,
46 
 42   Mabthera   -   -   -   -   15件:
11,
13,
35,
46,
50,
51,
53,
61,
63,
64,
65,
83,
162,
222,
271 
 43   Mabthera®   -   -   -   -   6件:
13,
35,
43,
44,
46,
93 
 44   Mabthéra   -   -   -   -   2件:
35,
162 
 45   Mathéra   -   -   -   -   2件:
35,
162 
 46   Methotrexate   Methotrexate   D00142, D02115   2件: DHFR, DHFR2   2件: Folate biosynthesis, One carbon pool by folate   33件:
11,
13,
19,
34,
35,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
55,
56,
60,
62,
65,
84,
93,
96,
97,
162,
164,
172,
256,
271,
284,
285,
326,
331 
 47   Methylprednisolone   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   36件:
2,
13,
25,
26,
35,
38,
39,
40,
41,
42,
43,
45,
46,
49,
50,
51,
60,
63,
64,
65,
66,
83,
84,
86,
96,
97,
145,
164,
220,
222,
224,
271,
283,
284,
285,
296 
 48   Micofenolato mofetilo   -   -   -   -   1件:
35 
 49   Mycophenolate   Mycophenolic acid   D05096   2件: IMPDH1, IMPDH2   1件: Purine metabolism   33件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
84,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 50   Mycophenolate mofetil   Mycophenolic acid, Mycophenolate mofetil, mycophenolate mofetil   D00752, D05094, D05095, D05096   2件: IMPDH1, IMPDH2   1件: Purine metabolism   32件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 51   Mycophenolate mofetil (mmf) 3 g/day   Mycophenolic acid, Mycophenolate mofetil, mycophenolate mofetil   D00752, D05094, D05095, D05096   2件: IMPDH1, IMPDH2   1件: Purine metabolism   1件:
35 
 52   Mycophenolate mofetil 2 g/day   Mycophenolic acid, Mycophenolate mofetil, mycophenolate mofetil   D00752, D05094, D05095, D05096   2件: IMPDH1, IMPDH2   1件: Purine metabolism   1件:
35 
 53   Ofatumumab   Ofatumumab   D09314   1件: MS4A1   1件: Hematopoietic cell lineage   3件:
13,
35,
46 
 54   Ono-4059   -   -   -   -   1件:
35 
 55   Paracetamol   Acetaminophen   D00217   2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   5件:
3,
6,
13,
35,
46 
 56   Parsaclisib   Parsaclisib   D11437   1件: PIK3CD   3件: B cell receptor signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   2件:
35,
53 
 57   Petrolatum   Petrolatum   D05304, D05331   -   -   3件:
35,
158,
162 
 58   Pi-0824   PI-0824   -   -   -   1件:
35 
 59   Prednisolone   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   38件:
11,
13,
25,
26,
35,
38,
39,
41,
43,
44,
45,
46,
49,
50,
51,
56,
60,
61,
63,
64,
65,
66,
75,
81,
84,
85,
95,
96,
97,
113,
145,
162,
222,
269,
271,
296,
299,
300 
 60   Prednisone   Ethanol   D00068, D02798, D04855, D06542   -   -   43件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
61,
63,
64,
65,
66,
81,
84,
85,
86,
95,
96,
97,
113,
162,
164,
222,
224,
228,
251,
283,
284,
285,
288,
299,
300,
331 
 61   Prednisone/prednisolone   Prednisolone, Ethanol   D00068, D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02798, D03301, D04855, D06542   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
35 
 62   Prn1008   -   -   -   -   1件:
35 
 63   Prn1008 freebase   -   -   -   -   1件:
35 
 64   Prn1008 oral tablet   -   -   -   -   1件:
35 
 65   Rapamycin   Sirolimus   D00753   1件: MTOR   2件: Pathways in cancer, mTOR signaling pathway   16件:
2,
15,
34,
35,
46,
49,
51,
60,
61,
67,
86,
89,
158,
256,
278,
279 
 66   Recombinant human interleukin-2 (rhil-2)   Human interleukin-2   -   -   -   1件:
35 
 67   Rituximab   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   42件:
11,
13,
14,
17,
35,
36,
43,
44,
45,
46,
49,
50,
51,
52,
53,
56,
60,
61,
63,
64,
65,
66,
83,
84,
85,
86,
93,
94,
96,
97,
162,
222,
223,
229,
256,
271,
283,
284,
285,
288,
300,
331 
 68   Rituximab (mabthera® or rituxan®).   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   2件:
35,
61 
 69   Rituximab and cyclophosphamide iv   Cyclophosphamide, Rituximab   D00287, D02994, D07760   1件: MS4A1   1件: Hematopoietic cell lineage   1件:
35 
 70   Ro0452294/v02   -   -   -   -   3件:
35,
43,
44 
 71   Ro1061443/f02   -   -   -   -   1件:
35 
 72   Silver   Silver   -   -   -   2件:
35,
162 
 73   Sirolimus   Sirolimus   D00753   1件: MTOR   2件: Pathways in cancer, mTOR signaling pathway   30件:
13,
17,
34,
35,
36,
46,
51,
60,
62,
63,
65,
66,
67,
85,
89,
96,
98,
137,
157,
158,
192,
222,
277,
278,
279,
280,
281,
283,
285,
331 
 74   Sirolimus (formerly known as rapamycin)   Sirolimus   D00753   1件: MTOR   2件: Pathways in cancer, mTOR signaling pathway   1件:
35 
 75   Synt001   -   -   -   -   2件:
35,
61 
 76   Tirabrutinib   Tirabrutinib   -   -   -   2件:
35,
53 
 77   Triamcinolone   Triamcinolone   D00385, D00983, D00984, D00985, D06216   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   8件:
35,
46,
56,
70,
90,
96,
226,
298 
 78   Triamcinolone acetonide   Triamcinolone   D00385, D00983, D00984, D00985, D06216   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   3件:
35,
46,
56 
 79   Vay736   -   -   -   -   7件:
13,
35,
46,
49,
53,
85,
95 
 80   Water   Water   D00001   -   -   18件:
2,
5,
6,
13,
17,
19,
35,
46,
53,
57,
63,
65,
67,
84,
97,
226,
278,
299 
 81   Water for injection   Water   D00001   -   -   1件:
35 

先頭へ